DM
David Mead
CEO
Varigen Biosciences Corporation
I'm working on
a month ago
Options amplified
About
Varizymes provides novel enzymes and reagents that advance low complexity molecular amplification and detection technologies. The company has engineered and purified several hundred proteins for customers and for commercial use. VariSafe RNAs are nuclease-resistant, single-stranded RNAs suitable as process controls for RNA extraction from various sample matrices. These specially engineered, non-infectious, MS2 phage-like particles protect their contents from degradation by nucleases and can package sequences from any virus.
Partnering listings
Learn more
DM
Varigen Biosciences Corporation

Recombinant citrinin-free monascus pigment platform for heat-stable natural food colors

Fermentation-derived food colorant platform that produces citrinin-free Monascus red and yellow pigments in an engineered, food-grade fungal host. The water-soluble pigments can be blended to create red, orange, and brow...

TechnologyConceptualCompany
DM
Varigen Biosciences Corporation

Broad-spectrum DNA and RNA nuclease for removing extracellular nucleic acid contaminants

A nuclease enzyme that rapidly degrades contaminating DNA and RNA from crude samples in under 30 minutes, enabling cleaner downstream detection of microbial nucleic acids. No specialized equipment or workflows required.

TechnologyIn developmentCompany
DM
Varigen Biosciences Corporation

Synbio tools for microbial crop protection against fungal and oomycete pathogens

Synthetic biology platform using engineered Bacillus subtilis to produce novel antifungal and anti-oomycete natural products. Enables sustainable biocontrol agents for crop protection against pathogens like Fusarium, Rhi...

TechnologyConceptualCompany
DM
Varigen Biosciences Corporation

Rapid rrna-based molecular detection of microbial and fungal species

A rapid, affordable molecular diagnostic platform using loop-mediated isothermal amplification (LAMP) targeting ribosomal RNA to detect bacterial and fungal pathogens in under 30 minutes. Lyophilized reagents eliminate c...

TechnologyIn developmentCompany
DM
Varigen Biosciences Corporation

Synthetic biology platform for enhancing microbial natural product yields

Varigen Biosciences offers a proprietary platform for capturing, manipulating, and expressing large biosynthetic gene clusters to unlock novel natural product metabolites. The technology accelerates discovery of bioactiv...

Consulting serviceCompany
DM
Varigen Biosciences Corporation

Prokaryotic RNA virus vaccine platform for avian immunity

Innovative platform using engineered MS2 bacteriophage virus-like particles to deliver vaccines for chickens, ensuring robust immune responses. This technology offers cost-effective, safe, and scalable vaccine production...

TechnologyConceptualCompany
DM
Varigen Biosciences Corporation

Rapid diagnostic method for seed health using multiplex LAMP technology

Varigen Biosciences introduces a multiplex LAMP (mLAMP) method for rapid, sensitive detection of viable pathogens in seeds. This scalable technique combines viability dyes and mLAMP to deliver results in 30 minutes, suit...

TechnologyIn developmentCompany
DM
David Mead
CEO
Varigen Biosciences Corporation
Work experience
Varigen Biosciences Corporation
CEO
2016 - Present
Top industry applications
Medical diagnostics
Expertise
GenomicsMicrobiologyMycologyPlant BiologyPlant PathologySynthetic Biology
Last updated Aug 2026
Halo home
Partner smarter. Move faster.
Get new partnering requests
delivered to your inbox.